Tag Archives: Chris Bunka

Lexaria - Nicotine - Television

Lexaria Announces R&D on Nicotine

Lexaria Announces R&D on Nicotine

KELOWNA, British Columbia, May 4, 2017 /Weed Wire/ — Lexaria Bioscience Corp (OTCQB:LXRP) (CSE:LXX) (the “Company”, “Lexaria”) is announcing new plans to commence nicotine absorption research beginning in the summer of 2017, within its previously announced R&D budget that is fully funded.

Lexaria - Nicotine - Television

Lexaria Extends Investor Relations Agreement

KELOWNA, British Columbia, Dec. 22, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) announces it has extended the services of Frontier Merchant Capital Group (“Frontier”) with a head office in Toronto, Canada, for a period of three months. Lexaria will pay CDN $25,000 + GST.

Lexaria - Nicotine - Television

Lexaria Files International Cannabinoid Patent Applications

KELOWNA, British Columbia, Dec. 19, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) is pleased to announce, following the successful October 26, 2016 issuance of its U.S. Patent No. 9,474,725, Cannabinoid Infused Food and Beverage Compositions and Methods of Use Thereof, it has filed to expand this patent internationally.

Lexaria - Nicotine - Television

Hempco Food and Fibre Inc. to Utilize Lexaria’s Patented Technology

KELOWNA, British Columbia, Nov. 30, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (“the Company” or “Lexaria”) is pleased to announce the entry of a letter of intent (the “LOI”) for the licensing of its proprietary absorption and palatability enhancing technology to Hempco Food and Fiber Inc. (TSXV: HEMP) (“Hempco®”).

Lexaria - Nicotine - Television

Lexaria Enters Memorandum of Understanding Establishing a Joint Venture with NeutriSci International Inc.

KELOWNA, British Columbia, Nov. 22, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) and NeutrisSci International Inc. (“Neutrisci”) (TSX-V:NU, Frankfurt-1N9) are pleased to announce the signing of a Memorandum of Understanding forming a 50/50 Joint Venture.

Lexaria - Nicotine - Television

Lexaria Bioscience Announces Issuance of U.S. Patent for Cannabinoid Infused Edibles

KELOWNA, British Columbia, Oct. 26, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) is pleased to announce the U.S. Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 9,474,725 pertaining to Lexaria’s method of improving bioavailability and taste of certain cannabinoid lipophilic active agents in food products.

Lexaria - Nicotine - Television

Lexaria Appoints New Auditors

KELOWNA, British Columbia,Oct. 6, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) announces it has appointed Davidson and Company, LLP, Chartered Professional Accountants, as its new independent registered public auditing firm for its fiscal year ending August 31, 2016.

Lexaria - Nicotine - Television

Lexaria Closes Final Tranche of Fully Subscribed Financing

KELOWNA, British Columbia, Aug. 31, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) announces it has closed the final tranche of the private placement equity financing announced July 5. The Company is pleased that the financing was fully subscribed.

Lexaria - Nicotine - Television

New LOI Signed to Out-License Lexaria’s Technology

KELOWNA, British Columbia, Aug. 30, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (“the Company” or “Lexaria”) has entered a new letter of intent (LOI) to license its proprietary absorption and palatability enhancing technology for cannabinoids and other bioactive substances.

Lexaria - Nicotine - Television

Lexaria Signs Letter of Intent for Second Technology Out-Licensing Agreement including Plans to Enter Clinical Studies

KELOWNA, British Columbia, Aug. 10, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (“the Company” or “Lexaria”) has entered a letter of intent (LOI) to license its proprietary technology to CBDM LLC for the development and sale of a range of marijuana oil infused product.

Lexaria - Nicotine - Television

Lexaria Receives Notice of Allowance of First Patent by US Patent Office

KELOWNA, British Columbia, July 12, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company”) is very pleased to announce a watershed event in its advancement as a bioscience company: it has just received its first Notice of Allowance for one of its US patent applications from the US Patent and Trademark Office (USPTO).

Lexaria-230x130

Lexaria Intends to Complete an Equity Financing of CDN$100,000

KELOWNA, British Columbia, May 31, 2016 /Weed Wire/ — Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) reports its intention to complete a non-brokered private placement financing of 700,000 equity units priced at US$0.11.

Lexaria-230x130

Lexaria’s CEO Chris Bunka Will be Speaking at the Widely Acclaimed Cannabis Growth Capital Summit

KELOWNA, British Columbia, May 26, 2016 /Weed Wire/ — Lexaria is pleased to announce that CEO Chris Bunka will be speaking at the widely acclaimed Cannabis Growth Capital Summit on June 15 in New York. Investors and supports are encouraged to register for this highly anticipated event!

Lexaria

Lexaria Announces Groundbreaking Technology Licensing Agreement

KELOWNA, British Columbia, March 22, 2016 /Weed Wire/ — Lexaria, Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) is very pleased to announced it has effected a Letter of Intent to license its patent pending technology for the purpose of entering the U.S. regulated medical and adult use cannabis edibles marketplace.

Lexaria-230x130

Lexaria Intends to Complete a Convertible Debenture Financing of US$400,000 and an Equity Financing of US$400,000

KELOWNA, British Columbia, Feb. 18, 2016 /Weed Wire/ — Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) reports its intention to complete a convertible debenture financing of up to US$400,000 that pays 10% simple interest per annum, with a 4 1/2 year term.

Capital Markets

Making CBD, and the Capital Markets, Bioavailable

Chris Bunka, the CEO and Chair at Lexaria Corp. (CSE: LXX) (OTCQB: LXRP), suspects that market-makers and broker-dealers are engaged in something potentially illegal and certainly untoward in connection with the stock of the company.

Lexaria

Lexaria Products SOLD OUT in Vegas; Coffee and Cocoa Introduction.

KELOWNA, British Columbia, Nov. 17, 2015 /Weed Wire/ — Lexaria Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) announces an overwhelmingly positive response to the new Lexaria Energy Protein Bar at its unveiling at three investment and business trade show conferences in Las Vegas, November 9 through November 13.

Cannabis Growth Capital Summit

Cannabis Growth Capital Conference, Las Vegas, Nov. 10-11, Announces All-Star Speaker Line-Up

CHICAGO, Oct. 20, 2015 /Weed Wire/ — The Cannabis Growth Capital Conference will bring the best public and private investment companies in the industry together at the Westgate Convention Center, Las Vegas, Nov. 10-11.

Lexaria and McKechnie and Financing and Partner Membership Product

Lexaria Announces Product Update and International Expansion

KELOWNA, British Columbia, Oct. 8, 2015 /Weed Wire/ — Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) is pleased to announce that the manufacturing process to infuse active hemp oil utilizing Lexaria’s patent pending technology designed to provide higher bioavailability, has been completed for both coffee and hot chocolate.

Lexaria and McKechnie and Financing and Partner Membership Product

Lexaria Corp. Announces Enrollment in MJIC Media’s Partner Membership

VANCOUVER, Sept. 23, 2015 /Weed Wire/ — Lexaria Corp. (OTCQB: LXRP), a food sciences company focused on food products derived from legal full spectrum bio-availability enhanced hemp oil, today announced that it has enrolled in MJIC Media’s Partner Membership.

Lexaria and McKechnie and Financing and Partner Membership Product

Amended: Lexaria Intends to Complete a US $2,520,000 Financing

KELOWNA, B.C., Sept. 18, 2015 /Weed Wire/ — Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) reports its intention to complete a non-brokered private placement financing, consisting of 14,000,000 Equity Units at US$0.18 per unit, to raise gross proceeds of up to US $2,520,000 (the “Private Placement”).


Top